Cargando...

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

BACKGROUND: Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival, which is highly variable amongst patients with comparable conventional prognosticators. Therefore molecular biomarkers are urgently needed to improve the prediction of survival in these patients. SRY (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Surg
Main Authors: ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600089/
https://ncbi.nlm.nih.gov/pubmed/28692180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.10553
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!